[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2015-2023 World Opioid-induced Constipation Market Research Report by Product Type, End-User (Application) and Regions (Countries)

March 2018 | 116 pages | ID: 2B0DA83A817EN
HeyReport

US$ 2,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

Market Segment as follows:

By Region / Countries
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain etc)
  • Asia-Pacific (China, India, Japan, Southeast Asia etc)
  • South America (Brazil, Argentina etc)
  • Middle East & Africa (Saudi Arabia, South Africa etc)
By Type
  • Solid
  • Liquid
By End-User / Application
  • Drugstore
  • Hospital
  • Others
By Company
  • AstraZeneca
  • Takeda Pharmaceutical
  • Valeant Pharmaceuticals International
  • Abbott
  • Bayer
  • Boehringer Ingelheim
  • C.B. Fleet
  • Cosmo Pharmaceuticals
  • Daewoong
  • Daiichi Sankyo
  • GlaxoSmithKline
  • Ironwood Pharmaceuticals
  • Johnson & Johnson
  • Merck
  • Mundipharma
  • Nektar Therapeutics
  • Pfizer
  • Progenics Pharmaceuticals
  • Shionogi
  • SLA Pharma
  • Sucampo
  • Synergy Pharmaceuticals
  • Theravance
1 MARKET DEFINITION

1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use/Application

2 GLOBAL MARKET BY VENDORS

2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 GLOBAL MARKET BY TYPE

3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 GLOBAL MARKET BY END-USE/APPLICATION

4.1 Market Share
4.2 Overview of Consumption Characteristics
  4.2.1 Preference Driven
  4.2.2 Substitutability
  4.2.3 Influence by Strategy
  4.2.4 Professional Needs

5 GLOBAL MARKET BY REGIONS

5.1 Market Share
5.2 Regional Market Growth
  5.2.1 North America
  5.2.2 Europe
  5.2.3 Asia-Pacific
  5.2.4 South America
  5.2.5 Middle East & Africa

6 NORTH AMERICA MARKET

6.1 by Type
6.2 by End-Use/Application
6.3 by Regions

7 EUROPE MARKET

7.1 by Type
7.2 by End-Use/Application
7.3 by Regions

8 ASIA-PACIFIC MARKET

8.1 by Type
8.2 by End-Use/Application
8.3 by Regions

9 SOUTH AMERICA MARKET

9.1 by Type
9.2 by End-Use/Application
9.3 by Regions

10 MIDDLE EAST & AFRICA MARKET

10.1 by Type
10.2 by End-Use/Application
10.3 by Regions

11 MARKET FORECAST

11.1 Global Market Forecast (2018-2023)
11.2 Market Forecast by Regions (2018-2023)
11.3 Market Forecast by Type (2018-2023)
11.4 Market Forecast by End-Use/Application (2018-2023)

12 KEY MANUFACTURERS

12.1 AstraZeneca
  12.1.2 Company Overview
  12.1.2 Product and End-User/Application
  12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Takeda Pharmaceutical
  12.2.1 Company Overview
  12.2.2 Product and End-User/Application
  12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 Valeant Pharmaceuticals International
  12.3.1 Company Overview
  12.3.2 Product and End-User/Application
  12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 Abbott
  12.4.1 Company Overview
  12.4.2 Product and End-User/Application
  12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 Bayer
  12.5.1 Company Overview
  12.5.2 Product and End-User/Application
  12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.6 Boehringer Ingelheim
  12.12.1 Company Overview
  12.12.2 Product and End-User/Application
  12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.7 C.B. Fleet
  12.7.1 Company Overview
  12.7.2 Product and End-User/Application
  12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.8 Cosmo Pharmaceuticals
  12.8.1 Company Overview
  12.8.2 Product and End-User/Application
  12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.9 Daewoong
  12.9.1 Company Overview
  12.9.2 Product and End-User/Application
  12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.10 Daiichi Sankyo
  12.10.1 Company Overview
  12.10.2 Product and End-User/Application
  12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.11 GlaxoSmithKline
12.12 Ironwood Pharmaceuticals
12.13 Johnson & Johnson
12.14 Merck
12.15 Mundipharma
12.16 Nektar Therapeutics
12.17 Pfizer
12.18 Progenics Pharmaceuticals
12.19 Shionogi
12.20 SLA Pharma
12.21 Sucampo
12.22 Synergy Pharmaceuticals
12.23 Theravance

9 RESEARCH CONCLUSION

LIST OF TABLES

Table Global Opioid-induced Constipation Market and Growth by Type
Table Global Opioid-induced Constipation Market and Growth by End-Use / Application
Table Global Opioid-induced Constipation Revenue (Million USD) by Vendors (2015-2017)
Table Global Healthcare & Medical Revenue Share by Vendors (2015-2017)
Table Global Opioid-induced Constipation Market Volume (Volume) by Vendors (2015-2017)
Table Global Opioid-induced Constipation Market Volume Share by Vendors (2015-2017)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Opioid-induced Constipation Market (Million USD) by Type (2015-2017)
Table Global Opioid-induced Constipation Market Share by Type (2015-2017)
Table Global Opioid-induced Constipation Market Volume (Volume) by Type (2015-2017)
Table Global Opioid-induced Constipation Market Volume Share by Type (2015-2017)
Table Global Opioid-induced Constipation Market (Million USD) by End-Use / Application (2015-2017)
Table Global Opioid-induced Constipation Market Share by End-Use / Application (2015-2017)
Table Global Opioid-induced Constipation Market Volume (Volume) by End-Use / Application (2015-2017)
Table Global Opioid-induced Constipation Market Volume Share by End-Use / Application (2015-2017)
Table Global Opioid-induced Constipation Market (Million USD) by Regions (2015-2017)
Table Global Opioid-induced Constipation Market Share by Regions (2015-2017)
Table Global Opioid-induced Constipation Market Volume (Volume) by Regions (2015-2017)
Table Global Opioid-induced Constipation Market Volume Share by Regions (2015-2017)
Table North America Opioid-induced Constipation Market (Million USD) by Type (2015-2017)
Table North America Opioid-induced Constipation Market Share by Type (2015-2017)
Table North America Opioid-induced Constipation Market (Million USD) by End-Use / Application (2015-2017)
Table North America Opioid-induced Constipation Market Share by End-Use / Application (2015-2017)
Table North America Opioid-induced Constipation Market (Million USD) by Regions (2015-2017)
Table North America Opioid-induced Constipation Market Share by Regions (2015-2017)
Table Europe Opioid-induced Constipation Market (Million USD) by Type (2015-2017)
Table Europe Opioid-induced Constipation Market Share by Type (2015-2017)
Table Europe Opioid-induced Constipation Market (Million USD) by End-Use / Application (2015-2017)
Table Europe Opioid-induced Constipation Market Share by End-Use / Application (2015-2017)
Table Europe Opioid-induced Constipation Market (Million USD) by Regions (2015-2017)
Table Europe Opioid-induced Constipation Market Share by Regions (2015-2017)
Table Asia-Pacific Opioid-induced Constipation Market (Million USD) by Type (2015-2017)
Table Asia-Pacific Opioid-induced Constipation Market Share by Type (2015-2017)
Table Asia-Pacific Opioid-induced Constipation Market (Million USD) by End-Use / Application (2015-2017)
Table Asia-Pacific Opioid-induced Constipation Market Share by End-Use / Application (2015-2017)
Table Asia-Pacific Opioid-induced Constipation Market (Million USD) by Regions (2015-2017)
Table Asia-Pacific Opioid-induced Constipation Market Share by Regions (2015-2017)
Table South America Opioid-induced Constipation Market (Million USD) by Type (2015-2017)
Table South America Opioid-induced Constipation Market Share by Type (2015-2017)
Table South America Opioid-induced Constipation Market (Million USD) by End-Use / Application (2015-2017)
Table South America Opioid-induced Constipation Market Share by End-Use / Application (2015-2017)
Table South America Opioid-induced Constipation Market (Million USD) by Regions (2015-2017)
Table Middle East & Africa Opioid-induced Constipation Market Share by Regions (2015-2017)
Table Middle East & Africa Opioid-induced Constipation Market (Million USD) by Type (2015-2017)
Table Middle East & Africa Opioid-induced Constipation Market Share by Type (2015-2017)
Table Middle East & Africa Opioid-induced Constipation Market (Million USD) by End-Use / Application (2015-2017)
Table Middle East & Africa Opioid-induced Constipation Market Share by End-Use / Application (2015-2017)
Table Middle East & Africa Opioid-induced Constipation Market (Million USD) by Regions (2015-2017)
Table Middle East & Africa Opioid-induced Constipation Market Share by Regions (2015-2017)
Table Global Opioid-induced Constipation Market (Million USD) Forecast by Regions (2018-2023)
Table Global Opioid-induced Constipation Market Share Forecast by Regions (2018-2023)
Table Global Opioid-induced Constipation Market Volume (Volume) Forecast by Regions (2018-2023)
Table Global Opioid-induced Constipation Market Volume Share Forecast by Regions (2018-2023)
Table Global Opioid-induced Constipation Market (Million USD) Forecast by Type (2018-2023)
Table Global Opioid-induced ConstipationMarket Share by Forecast Type (2018-2023)
Table Global Opioid-induced Constipation Market (Million USD) Forecast by End-Use / Application (2018-2023)
Table Global Opioid-induced Constipation Market Share Forecast by End-Use / Application (2018-2023)
Table Sales Revenue, Volume, Price, Cost and Margin of AstraZeneca
Table Sales Revenue, Volume, Price, Cost and Margin of Takeda Pharmaceutical
Table Sales Revenue, Volume, Price, Cost and Margin of Valeant Pharmaceuticals International
Table Sales Revenue, Volume, Price, Cost and Margin of Abbott
Table Sales Revenue, Volume, Price, Cost and Margin of Bayer
Table Sales Revenue, Volume, Price, Cost and Margin of Boehringer Ingelheim
Table Sales Revenue, Volume, Price, Cost and Margin of C.B. Fleet
Table Sales Revenue, Volume, Price, Cost and Margin of Cosmo Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Daewoong
Table Sales Revenue, Volume, Price, Cost and Margin of Daiichi Sankyo
Table Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline
Table Sales Revenue, Volume, Price, Cost and Margin of Ironwood Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Johnson & Johnson
Table Sales Revenue, Volume, Price, Cost and Margin of Merck
Table Sales Revenue, Volume, Price, Cost and Margin of Mundipharma
Table Sales Revenue, Volume, Price, Cost and Margin of Nektar Therapeutics
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of Progenics Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Shionogi
Table Sales Revenue, Volume, Price, Cost and Margin of SLA Pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Sucampo
Table Sales Revenue, Volume, Price, Cost and Margin of Synergy Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Theravance

LIST OF FIGURES

Figure Global Opioid-induced Constipation Market Size (Million USD) 2012-2022
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2015-2017
Figure Asia-Pacific Market Growth 2015-2017
Figure South America Market Growth 2015-2017
Figure Middle East & Africa Market Growth 2015-2017
Figure Global Opioid-induced Constipation Market (Million USD) and Growth Forecast (2018-2023)
Figure Global Opioid-induced Constipation Market Volume (Volume) and Growth Forecast (2018-2023)


More Publications